{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:17:38Z","timestamp":1780582658001,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Brazilian Agencies FAPERGS","award":["2261-12"],"award-info":[{"award-number":["2261-12"]}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["302797\/2016-5"],"award-info":[{"award-number":["302797\/2016-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bjid.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T23:00:16Z","timestamp":1511391616000},"page":"30-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil"],"prefix":"10.1016","volume":"22","author":[{"given":"Laura","family":"Bedin Denardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Hoch Dalla-Lana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francielli","family":"Pantella Kunz de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Bittencourt Severo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janio","family":"Morais Santurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis Adriel","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Hartz Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2017.10.005_bib0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.bjid.2017.10.005_bib0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1751-7915.12367","article-title":"Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species","volume":"10","author":"Paulussen","year":"2017","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.bjid.2017.10.005_bib0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.005_bib0180","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.005_bib0185","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.bjid.2017.10.005_bib0190","doi-asserted-by":"crossref","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bjid.2017.10.005_bib0195","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","author":"Fuhren","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0200","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/JCM.00535-08","article-title":"In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2017.10.005_bib0205","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3201\/eid2009.140142","article-title":"Passive surveillance for azole resistant Aspergillus fumigatus, United States, 2011\u20132013","volume":"20","author":"Pham","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.005_bib0210","first-page":"315","article-title":"Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics","volume":"38","author":"White","year":"1990","journal-title":"PCR Protoc Guide Methods Appl"},{"key":"10.1016\/j.bjid.2017.10.005_bib0215","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1111\/1469-0691.12148","article-title":"European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on voriconazole and Aspergillus spp","volume":"19","author":"Hope","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2017.10.005_bib0220","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2017.10.005_bib0225","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.02661-13","article-title":"Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serum","volume":"58","author":"Elefanti","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0230","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.bjid.2017.10.005_bib0235","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.01730-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 Document)","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0240","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","article-title":"Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in The Netherlands","volume":"70","author":"van Ingen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0250","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/JCM.00213-11","article-title":"Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance","volume":"49","author":"Mortensen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2017.10.005_bib0255","unstructured":"FRAC. FRAC cod list. FRAC information: list of resistance. Available in: http:\/\/www.frac-br.org\/ [accessed in 22.07.17]."},{"key":"10.1016\/j.bjid.2017.10.005_bib0260","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3201\/eid2201.150978","article-title":"Multiple fungicide-driven alterations in azole-resistant Aspergillus fumigatus, Colombia, 2015","volume":"22","author":"Le Pape","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.005_bib0265","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.riam.2016.05.005","article-title":"First itraconazole resistant Aspergillus fumigatus clinical isolate harbouring a G54E substitution in CYP51AP in South America","volume":"34","author":"Leonardelli","year":"2017","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2017.10.005_bib0270","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"Van der Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2017.10.005_bib0275","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00608-17","article-title":"Triazole resistance is still not emerging in A. fumigatus isolates causing invasive aspergillosis in Brazilian patients","author":"Negri","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0280","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","article-title":"In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs","volume":"54","author":"Shivaprakash","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2017.10.005_bib0285","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.01902-12","article-title":"In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi","volume":"57","author":"Gon\u00e7alves","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0290","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2017.10.005_bib0295","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.drup.2006.01.001","article-title":"Update on antifungal drug resistance mechanisms of Aspergillus fumigatus","volume":"8","author":"Chamilos","year":"2005","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bjid.2017.10.005_bib0300","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0305","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00004-17","article-title":"Genetic diversity and in vitro antifungal susceptibility of 200 clinical and environmental Aspergillus flavus isolates","volume":"61","author":"Taghizadeh-Armaki","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0310","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/AAC.00699-07","article-title":"Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia","volume":"52","author":"Antachopoulos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2017.10.005_bib0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diagmicrobio.2010.01.001","article-title":"Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods","volume":"67","author":"Pfaller","year":"2010","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017308449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017308449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T22:08:50Z","timestamp":1535234930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867017308449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1413867017308449"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2017.10.005","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}